- Dataminr to Acquire ThreatConnect in $290 M Deal
The AI‑driven real‑time event detection firm Dataminr is acquiring ThreatConnect, which specialises in internal threat management, in a move to blend public‑data signals with enterprise internal telemetry and deliver “client‑tailored” cyber‑intelligence.
Why this matters: For enterprise tech vendors it signals that AI‑powered intelligence platforms are becoming strategic acquisitions in B2B security.
Anthropic – Google Deal Reportedly Worth “Tens of Billions”
Anthropic, the generative‑AI startup behind the Claude chatbot, is reportedly negotiating a massive cloud‑computing deal with Google worth “tens of billions”, underlining how infrastructure access is now a core B2B battleground for enterprise AI.
Take‑away: As you run your AI consulting company, this emphasises how compute access and partnership scale are becoming part of the go‑to‑market playbook.
Cambrex to Invest $120 M to Expand U.S. Drug Manufacturing
The contract development & manufacturing organisation Cambrex is investing US$120 million to expand its API manufacturing capacity at its Iowa facility, in response to reshoring and supply‑chain resilience initiatives in pharma/biotech.
Why it’s relevant: Industrial B2B firms are actively investing in capacity expansion and geo‑reshoring – a major strategic lever in supply‑chain‑driven sectors.
- What it Takes to Win Enterprise Technology deals in 2025
A new Forbes Council article outlines how today’s enterprise buyers expect vision, tangible results and a holistic ROI, rather than just product features.
For AI‑consulting firms (like yours!) this means that the value proposition must tie directly into business outcomes and operational change—not just “we deliver models”.
U‑Freight Group expands pharma & medical logistics capabilities with strategic partnership and major contract win
U‑Freight Group has deepened its strategic cooperation in China by providing logistics fulfilment for a new B2B e‑commerce platform focused on medical products, via its partner in Shanghai.
It underscores that B2B growth in Asia still relies heavily on supply‑chain, cold‑chain, and logistics infrastructure in addition to tech.
Dubai Chamber of Commerce concludes trade mission with Armenia meetings
Dubai Chamber of Commerce successfully concluded a trade mission arranging 301 B2B meetings between companies from Dubai and counterparts in Armenia, part of a push to deepen non‑oil trade and business partnerships in the Caucasus region.
This demonstrates how business development and cross‑border B2B sales efforts are increasingly global and strategic, not just local.
ChainUp Investment unveils blueprint for family offices; declares Bitcoin’s new highs confirm institutional era
ChainUp Investment announced that rising Bitcoin prices reflect crypto’s entry into the institutional‑phase, and laid out a framework for family‑offices and B2B asset‑managers to engage.
For B2B consulting / advisory practices, this is a reminder that emerging asset‑categories and financial services ecosystems are pushing adjacent B2B demand and new business models.
Cambrex to Invest $120 M to Expand U.S. Drug Manufacturing
The contract development & manufacturing organisation Cambrex is investing US$120 million to expand its API manufacturing capacity at its Iowa facility, in response to reshoring and supply‑chain resilience initiatives in pharma/biotech.
Why it’s relevant: Industrial B2B firms are actively investing in capacity expansion and geo‑reshoring – a major strategic lever in supply‑chain‑driven sectors.
